X

Vous n'êtes pas connecté

Maroc Maroc - THEMARKETHERALD.CA - A La Une - Hier 15:59

Oncolytics Biotech reports positive results from breast cancer study

Oncolytics Biotech (TSX:ONC) revealed results from its Phase 2 study in patients with advanced or metastatic breast cancer.

Articles similaires

New cancer drug shows encouraging results in Phase I/II trial

news.medical.net - 14/Sep 08:17

The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial...

Sorry! Image not available at this time

Trishula Therapeutics Presents Positive Results from Phase 1 Trial of TTX-030 in First-Line Metastatic Pancreatic Cancer Patients

drugs.com - 16/Sep 14:09

SOUTH SAN FRANCISCO, Calif., Sept. 16, 2024. Trishula Therapeutics, Inc., a clinical stage, privately held biotechnology company, today reported final...

Sorry! Image not available at this time

Relay Stock Soars on Upbeat Data From Breast Cancer Study

zacks.com - 10/Sep 14:55

RLAY stock soars on positive interim efficacy data from the early-stage study of its doublet therapy, RLY-2608 in combination with Faslodex, for...

Sorry! Image not available at this time

Relay Stock Soars on Upbeat Data From Breast Cancer Study

zacks.com - 10/Sep 14:55

RLAY stock soars on positive interim efficacy data from the early-stage study of its doublet therapy, RLY-2608 in combination with Faslodex, for...

Imugene gets crucial FDA nod for bile tract cancer drug

thewest.com.au - 18/Sep 06:47

Imugene has landed a prized FDA orphan drug approval for its bile tract cancer therapy following positive results from its recent metastatic advanced...

Imugene gets crucial FDA nod for bile tract cancer drug

thewest.com.au - 18/Sep 06:47

Imugene has landed a prized FDA orphan drug approval for its bile tract cancer therapy following positive results from its recent metastatic advanced...

Sorry! Image not available at this time

Crestone Announces Positive Data From Phase 2 Clinical Trial of CRS3123 for C. Difficile Infections (CDI)

drugs.com - 05/Sep 05:09

BOULDER, Colo.--(BUSINESS WIRE)-- September 05, 2024 -- Crestone, Inc. (“Crestone”) today announced positive topline results from the Phase 2...

Sorry! Image not available at this time

Crestone Announces Positive Data From Phase 2 Clinical Trial of CRS3123 for C. Difficile Infections (CDI)

drugs.com - 05/Sep 05:09

BOULDER, Colo.--(BUSINESS WIRE)-- September 05, 2024 -- Crestone, Inc. (“Crestone”) today announced positive topline results from the Phase 2...

Experimental mRNA Cancer Vaccine Shows Promise in Phase 1 Trial

medindia.net - 14/Sep 10:51

An experimental mRNA cancer vaccine shows promising results in a Phase 1 trial, potentially offering new hope for advanced-stage cancer patients.